Osha Roopnarine

Dr. Osha Roopnarine

orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 November 2022 in Biomolecules
Verified
Journal Article
Open access
PDF file
PBPhilip Bidwell
Philip Bidwell
SYSamantha L. Yuen
Samantha L. Yuen
JLJi Li
Ji Li
KRKaja Rozman
Kaja Rozman
RRRobyn Rebbeck
Robyn Rebbeck
DTDavid Thomas
David Thomas
The sarco/endoplasmic reticulum Ca-ATPase (SERCA) is a P-type ion pump that transports Ca2+ from the cytosol into the endoplasmic/sarcoplasmic reticulum (ER/SR) in most mammalian cells. It is critically important in muscle, facilitating relaxation and enabling subsequent contraction. Increasing SERCA expression or specific activity can alleviate muscle dysfunction, most notably in the heart, and we seek to develop small-molecule drug candidates that activate SERCA. Therefore, we adapted an NADH-coupled assay, measuring Ca-dependent ATPase activity of SERCA, to high-throughput screening (HTS) format, and screened a 46,000-compound library of diverse chemical scaffolds. This HTS platform yielded numerous hits that reproducibly alter SERCA Ca-ATPase activity, with few false positives. The top 19 activating hits were further tested for effects on both Ca-ATPase and Ca2+ transport, in both cardiac and skeletal SR. Nearly all hits increased Ca2+ uptake in both cardiac and skeletal SR, with some showing isoform specificity. Furthermore, dual analysis of both activities identified compounds with a range of effects on Ca2+-uptake and ATPase, which fit into distinct classifications. Further study will be needed to identify which classifications are best suited for therapeutic use. These results reinforce the need for robust secondary assays and criteria for selection of lead compounds, before undergoing HTS on a larger scale.


1 July 2023 in Scientific Reports
Verified
Journal Article
Open access
PDF file
OROsha Roopnarine
Osha Roopnarine
SYSamantha L. Yuen
Samantha L. Yuen
ATAndrew R. Thompson
Andrew R. Thompson
LRLauren N. Roelike
Lauren N. Roelike
RRRobyn T. Rebbeck
Robyn T. Rebbeck
DTDavid Thomas
David Thomas
We have used FRET-based biosensors in live cells, in a robust high-throughput screening (HTS) platform, to identify small-molecules that alter the structure and activity of the cardiac sarco/endoplasmic reticulum calcium ATPase (SERCA2a). Our primary aim is to discover drug-like small-molecule activators that improve SERCA’s function for the treatment of heart failure. We have previously demonstrated the use of an intramolecular FRET biosensor, based on human SERCA2a, by screening two different small validation libraries using novel microplate readers that detect the fluorescence lifetime or emission spectrum with high speed, precision, and resolution. Here we report results from FRET-HTS of 50,000 compounds using the same biosensor, with hit compounds functionally evaluated using assays for Ca2+-ATPase activity and Ca2+-transport. We focused on 18 hit compounds, from which we identified eight structurally unique scaffolds and four scaffold classes as SERCA modulators, approximately half of which are activators and half are inhibitors. Five of these compounds were identified as promising SERCA activators, one of which activates Ca2+-transport even more than Ca2+-ATPase activity thus improving SERCA efficiency. While both activators and inhibitors have therapeutic potential, the activators establish the basis for future testing in heart disease models and lead development, toward pharmaceutical therapy for heart failure.

14 January 2023 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
MRMark D. Rustad
Mark D. Rustad
OROsha Roopnarine
Osha Roopnarine
RCRazvan L Cornea
Razvan L Cornea
DTDavid Thomas
David Thomas

19 October 2023 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
EBElisa Bovo
Elisa Bovo
RRRobyn Rebbeck
Robyn Rebbeck
OROsha Roopnarine
Osha Roopnarine
RCRazvan L Cornea
Razvan L Cornea
DTDavid Thomas
David Thomas
AZAleksey V. Zima
Aleksey V. Zima

11 October 2023 in Applied Magnetic Resonance
Verified
Journal Article
Open access
PDF file
OROsha Roopnarine
Osha Roopnarine
DTDavid Thomas
David Thomas
Here we review applications of site-directed spin labeling (SDSL) with engineered cysteines in proteins, to study the structural dynamics of muscle and non-muscle proteins, using and developing the electron paramagnetic resonance (EPR) spectroscopic techniques of dipolar EPR, double electron electron resonance (DEER), saturation transfer EPR (STEPR), and orientation measured by EPR. The SDSL technology pioneered by Wayne Hubbell and collaborators has greatly expanded the use of EPR, including the measurement of distances between spin labels covalently attached to proteins and peptides. The Thomas lab and collaborators have applied these techniques to elucidate dynamic interactions in the myosin–actin complex, myosin-binding protein C, calmodulin, ryanodine receptor, phospholamban, utrophin, dystrophin, β-III-spectrin, and Aurora kinase. The ability to design and engineer cysteines in proteins for site-directed covalent labeling has enabled the use of these powerful EPR techniques to measure distances, while showing that they are complementary with optical spectroscopy measurements.